Select Your Region
Americas
Europe
Africa
Global
Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- Yellowstone
How does a new medicine (efmarodocokin alfa) compare to available medicine and placebo – in people with ulcerative colitis
Autoimmune Disorder Inflammatory Bowel Disease (IBD) Ulcerative Colitis
Study results
LPS GA39925 Yellowstone Final Results January 2023 Bulgarian
(PDF, 1.1 MB)
LPS GA39925 Yellowstone Final Results January 2023 English
(PDF, 0.5 MB)
LPS GA39925 Yellowstone Final Results January 2023 Georgian Kartuli ena
(PDF, 1.3 MB)
LPS GA39925 Yellowstone Final Results January 2023 German
(PDF, 1.0 MB)
LPS GA39925 Yellowstone Final Results January 2023 Greek
(PDF, 0.7 MB)
LPS GA39925 Yellowstone Final Results January 2023 Hebrew
(PDF, 0.7 MB)
LPS GA39925 Yellowstone Final Results January 2023 Hungarian
(PDF, 0.8 MB)
LPS GA39925 Yellowstone Final Results January 2023 Italian
(PDF, 1.1 MB)
LPS GA39925 Yellowstone Final Results January 2023 Polish
(PDF, 1.0 MB)
LPS GA39925 Yellowstone Final Results January 2023 Romanian
(PDF, 0.9 MB)
LPS GA39925 Yellowstone Final Results January 2023 Russian
(PDF, 1.0 MB)
LPS GA39925 Yellowstone Final Results January 2023 Serbian
(PDF, 1.0 MB)
LPS GA39925 Yellowstone Final Results January 2023 Spanish Spain
(PDF, 1.0 MB)
LPS GA39925 Yellowstone Final Results January 2023 Spanish USA
(PDF, 1.1 MB)
LPS GA39925 Yellowstone Final Results January 2023 Ukrainian
(PDF, 1.0 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com